STOCKS
Phio Pharmaceuticals -3.8%: the short on the sell signal is now 23.66% in profit
Phio Pharmaceuticals stock slips 3.8%, and the sell signal, now in week 8, has the short 23.66% in profit. The trade is in its management phase, and our model suggests following it with discipline, keeping the same approach for now.
Procter & Gamble +2.7%: coverage complete, the managed trade now 12.91% up
Procter & Gamble stock gains 2.7% and the buy signal, now in week 21, stands 12.91% up since entry. Our model's coverage is complete, and the remaining position carries on as the trade moves through its management phase.
Pfizer -1.7%: buy signal in week 14 still 7.96% up, model coverage complete
Pfizer stock slips 1.7% on the week, while the buy signal, now in week 14, is still 7.96% up since entry. The trade is in its management phase: the model's coverage is complete and the residual capital carries on.
Petroleo Brasileiro +1.3%: the sell signal has already cleared both model targets
Trading latinoamerica: Petroleo Brasileiro stock gains 1.3%, with the sell signal in week 3 and the short 13.56% in profit. Price has already moved past both model targets, and the model advises against a fresh short now.
PepsiCo +2.9%: the buy signal, now in week 3, stands 7.12% up since entry
PepsiCo stock gains 2.9%, and the buy signal, now in week 3, is 7.12% up since entry. Our model points to a standard position size, with the next scaling-out window due in week 6 for 10% of the position.
PDG Realty -9.5%: sell signal in week 11, with the short up 83.76%
Trading latinoamerica: PDG Realty stock falls 9.5% and the sell signal, now in week 11, stays in management with the short up 83.76%. With quarterly results out on November 13, our model suggests managing the trade with discipline.
PG&E +2.2%: the short stays 7.34% in profit in week 11 of the sell signal
PG&E stock rises 2.2%, while the sell signal, now in week 11, stays in its management phase with the short 7.34% in profit. Our model suggests following the trade with discipline, without getting distracted by the bounce.
Petroleo Brasileiro -1.0%: the short has already cleared both model targets
Petroleo Brasileiro stock slips 1.0% while the sell signal sits in week 3, with the short up 16.83%. Price has already moved past both targets, and our model advises against opening a new short at this stage.
Palo Alto Networks +2.7%: short 15.32% in profit with November 18 earnings ahead
Palo Alto Networks stock rises 2.7% as the sell signal, in week 4, keeps the short 15.32% in profit. Our model advises against opening a fresh short and flags November 18 earnings, which could bring wide swings.
Occidental Petroleum +4.2%: the sell signal comes under pressure in week 2
Occidental Petroleum stock rises 4.2%, putting pressure on the sell signal, now in week 2. Our model advises against opening a fresh short: historically, short selling on the signal has lost money on average, because shares tend to rise over time.
Oscar Health +1.3%: buy signal up 114.88% in week 31, model coverage complete
Oscar Health stock gains 1.3%, with the buy signal in week 31 and in its management phase. Our model's coverage is complete, and only the residual capital carries on, now sitting on a 114.88% gain since the trade was opened.
Oracle +8.0%: the short stays in profit as the trade enters its management phase
Oracle stock jumps 8.0%, yet the sell signal in week 5 holds and the short is still 2.25% in profit. This week the trade moves into its management phase, which our model suggests following with discipline.
Orange +3.4%: buy signal in its confirmation week, with a standard size
Orange stock gains 3.4% and the buy signal is in its confirmation week, 3.41% up since entry. Our model indicates a standard position size, with the next scaling-out window, for 10% of the position, due in week 6.
L'Oreal +0.3%: buy signal in week 24 sits 17.95% up, model coverage complete
L'Oreal stock edges up 0.3%, and the buy signal, now in week 24, stays in its management phase, 17.95% up since entry. The model's coverage is complete, with every reference level already reached and the residual capital still running.